[go: up one dir, main page]

AR101442A1 - Método para la expansión de células madre de adultos de sangre - Google Patents

Método para la expansión de células madre de adultos de sangre

Info

Publication number
AR101442A1
AR101442A1 ARP150101414A ARP150101414A AR101442A1 AR 101442 A1 AR101442 A1 AR 101442A1 AR P150101414 A ARP150101414 A AR P150101414A AR P150101414 A ARP150101414 A AR P150101414A AR 101442 A1 AR101442 A1 AR 101442A1
Authority
AR
Argentina
Prior art keywords
expansion
blood
mother cells
blood mother
blood sample
Prior art date
Application number
ARP150101414A
Other languages
English (en)
Inventor
Polettini Marco
Original Assignee
Thankstem S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thankstem S R L filed Critical Thankstem S R L
Publication of AR101442A1 publication Critical patent/AR101442A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Método para la expansión de células madre adultas de la sangre que comprenden el crecimiento y la desprogramación de células madre adultas de la sangre de una muestra de sangre obtenida, por medio de tratamiento in vitro de la muestra de sangre con MCSF y la ozonización de la muestra de sangre.
ARP150101414A 2014-05-09 2015-05-08 Método para la expansión de células madre de adultos de sangre AR101442A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUD20140075 2014-05-09

Publications (1)

Publication Number Publication Date
AR101442A1 true AR101442A1 (es) 2016-12-21

Family

ID=51136668

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150101414A AR101442A1 (es) 2014-05-09 2015-05-08 Método para la expansión de células madre de adultos de sangre

Country Status (21)

Country Link
US (1) US20170152482A1 (es)
EP (1) EP3140396B1 (es)
JP (1) JP6664382B2 (es)
KR (1) KR20170002568A (es)
CN (1) CN106574247A (es)
AR (1) AR101442A1 (es)
AU (1) AU2015257334B2 (es)
CA (1) CA2948096A1 (es)
DK (1) DK3140396T3 (es)
EA (1) EA035104B1 (es)
ES (1) ES2690253T3 (es)
HR (1) HRP20181542T1 (es)
HU (1) HUE040661T2 (es)
IL (1) IL248805A0 (es)
MA (1) MA39958B1 (es)
MX (1) MX369097B (es)
PL (1) PL3140396T3 (es)
RS (1) RS57793B1 (es)
SG (1) SG11201609306UA (es)
SI (1) SI3140396T1 (es)
WO (1) WO2015170291A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021023101A2 (pt) * 2019-05-22 2022-01-04 Thankstem S R L Método para expansão de células-tronco adultas do sangue total
JP2022078971A (ja) * 2020-11-13 2022-05-25 レネロファーマ株式会社 皮膚炎及び皮膚状態改善用オゾンバブリング装置及び皮膚炎及び皮膚状態改善方法
JP7403771B2 (ja) * 2020-11-13 2023-12-25 レネロファーマ株式会社 外傷性炎症改善用オゾンバブリング装置及び外傷性炎症改善方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591457A (en) * 1992-02-07 1997-01-07 Vasogen Inc Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human
JP3989949B2 (ja) * 1992-02-07 2007-10-10 バソジェン アイルランド リミテッド 血中の酸化窒素濃度を増加させる方法
TWI288779B (en) 2002-03-28 2007-10-21 Blasticon Biotech Forschung Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
US20040136973A1 (en) 2002-11-07 2004-07-15 Eliezer Huberman Human stem cell materials and methods
WO2004043990A2 (en) 2002-11-07 2004-05-27 University Of Chicago Human stem cell materials and methods
WO2007131200A2 (en) 2006-05-05 2007-11-15 Opexa Therapeutics Monocyte-derived stem cells
CN100471085C (zh) 2006-08-22 2009-03-18 华为技术有限公司 上行物理信道的功率控制方法及装置
ITRM20060498A1 (it) * 2006-09-20 2008-03-21 Alessandra Gambacurta Metodo di espansione di cellule staminali adulte da sangue periferico e relativi usi in campo medico
US20120269774A1 (en) * 2006-09-21 2012-10-25 Medistem Laboratories, Inc Allogeneic stem cell transplants in non-conditioned recipients
US20110104100A1 (en) * 2007-10-04 2011-05-05 Medistem Laboratories, Inc. Compositions and methods of stem cell therapy for autism
ITUD20080058A1 (it) * 2008-03-18 2009-09-19 Thankstem S R L Kit per la raccolta di sangue, preferibilmente periferico, per la produzione di cellule staminali

Also Published As

Publication number Publication date
SI3140396T1 (sl) 2018-11-30
EP3140396A1 (en) 2017-03-15
JP6664382B2 (ja) 2020-03-13
SG11201609306UA (en) 2016-12-29
WO2015170291A1 (en) 2015-11-12
EP3140396B1 (en) 2018-08-01
ES2690253T3 (es) 2018-11-20
KR20170002568A (ko) 2017-01-06
PL3140396T3 (pl) 2019-01-31
MA39958A (fr) 2017-03-15
MX369097B (es) 2019-10-29
RS57793B1 (sr) 2018-12-31
HUE040661T2 (hu) 2019-03-28
CA2948096A1 (en) 2015-11-12
IL248805A0 (en) 2017-01-31
EA035104B1 (ru) 2020-04-28
EA201650059A1 (ru) 2017-05-31
AU2015257334A1 (en) 2016-12-15
AU2015257334B2 (en) 2021-02-25
US20170152482A1 (en) 2017-06-01
MA39958B1 (fr) 2018-10-31
MX2016014628A (es) 2017-05-02
HRP20181542T1 (hr) 2018-11-30
DK3140396T3 (en) 2018-11-12
CN106574247A (zh) 2017-04-19
JP2017521088A (ja) 2017-08-03

Similar Documents

Publication Publication Date Title
CL2018000194A1 (es) Compuestos de piridina
CL2017000285A1 (es) Terapia combinada para el tratamiento de un paramixovirus
UY34201A (es) Compuestos de azaindol y métodos para el tratamiento de vih.
MX385749B (es) Composiciones que comprenden una caseína y métodos para producir las mismas.
CL2016002679A1 (es) Métodos para mejorar o acelerar la recuperación física después la cirugía por fractura de cadera.
CL2017003297A1 (es) Métodos de deshidratación de soluciones alcohólicas mediante osmosis y sistemas relacionados.
UY34657A (es) ?derivados macrocíclicos para el tratamiento de enfermedades?.
MX2016013963A (es) Metodos mejorados para la elaboracion de terapias celulares adoptivas.
UY34144A (es) ?proceso para la producción de carbonato de calcio precipitado, carbonato de calcio precipitado y sus usos
CL2017000806A1 (es) Compuestos anti-tnf
CL2018000596A1 (es) Nuevos compuestos bicíclicos como inhibidores de la atx
BR112018067525A2 (pt) anticorpos tendo especificidade para o btla e seus usos
CO2018001840A2 (es) Composiciones biofarmacéuticas que comprenden anticuerpos anti-il-5
UY34467A (es) Procedimiento para la preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
MX2013010557A (es) Anticuerpo del factor tisular humano y usos de este.
CL2017001632A1 (es) Manufactura de proteína.
MX2023006416A (es) Anticuerpos, usos y metodos.
IL292054A (en) Compositions for treatment of abnormal cell growth
MX2017000527A (es) Formulaciones de anticuerpos cristalinos.
JO3541B1 (ar) علاجات طبية قائمة على اناموريلين
MX2021006003A (es) Formulaciones de anticuerpos cristalinos.
CL2017003309A1 (es) Métodos de purificación y/o inactivación viral
MX2017002796A (es) Tasimelteon para tratar el sindrome de smith-magenis.
DK3189844T3 (da) Pluripotent stamcelle til behandling af diabetisk hudsår
BR112017020513A2 (pt) método de produção de peixe para transplante, peixe para transplante, método de produção de espécie híbrida de peixe e espécie híbrida de peixe

Legal Events

Date Code Title Description
FB Suspension of granting procedure
FB Suspension of granting procedure